Cargando…

Correction: Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)

Detalles Bibliográficos
Autores principales: Sivaprasad, Sobha, Crosby-Nwaobi, Roxanne, Esposti, Simona Degli, Peto, Tunde, Rajendram, Ranjan, Michaelides, Michel, Hykin, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763982/
http://dx.doi.org/10.1371/annotation/a9d300ac-887d-43b3-a9b1-425d33cdf13b
_version_ 1782283068149596160
author Sivaprasad, Sobha
Crosby-Nwaobi, Roxanne
Esposti, Simona Degli
Peto, Tunde
Rajendram, Ranjan
Michaelides, Michel
Hykin, Philip
author_facet Sivaprasad, Sobha
Crosby-Nwaobi, Roxanne
Esposti, Simona Degli
Peto, Tunde
Rajendram, Ranjan
Michaelides, Michel
Hykin, Philip
author_sort Sivaprasad, Sobha
collection PubMed
description
format Online
Article
Text
id pubmed-3763982
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37639822013-09-13 Correction: Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4) Sivaprasad, Sobha Crosby-Nwaobi, Roxanne Esposti, Simona Degli Peto, Tunde Rajendram, Ranjan Michaelides, Michel Hykin, Philip PLoS One Correction Public Library of Science 2013-09-04 /pmc/articles/PMC3763982/ http://dx.doi.org/10.1371/annotation/a9d300ac-887d-43b3-a9b1-425d33cdf13b Text en © 2013 Public Library of Science http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Sivaprasad, Sobha
Crosby-Nwaobi, Roxanne
Esposti, Simona Degli
Peto, Tunde
Rajendram, Ranjan
Michaelides, Michel
Hykin, Philip
Correction: Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)
title Correction: Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)
title_full Correction: Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)
title_fullStr Correction: Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)
title_full_unstemmed Correction: Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)
title_short Correction: Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)
title_sort correction: structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the bolt study (report 4)
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763982/
http://dx.doi.org/10.1371/annotation/a9d300ac-887d-43b3-a9b1-425d33cdf13b
work_keys_str_mv AT sivaprasadsobha correctionstructuralandfunctionalmeasuresofefficacyinresponsetobevacizumabmonotherapyindiabeticmacularoedemaexploratoryanalysesoftheboltstudyreport4
AT crosbynwaobiroxanne correctionstructuralandfunctionalmeasuresofefficacyinresponsetobevacizumabmonotherapyindiabeticmacularoedemaexploratoryanalysesoftheboltstudyreport4
AT espostisimonadegli correctionstructuralandfunctionalmeasuresofefficacyinresponsetobevacizumabmonotherapyindiabeticmacularoedemaexploratoryanalysesoftheboltstudyreport4
AT petotunde correctionstructuralandfunctionalmeasuresofefficacyinresponsetobevacizumabmonotherapyindiabeticmacularoedemaexploratoryanalysesoftheboltstudyreport4
AT rajendramranjan correctionstructuralandfunctionalmeasuresofefficacyinresponsetobevacizumabmonotherapyindiabeticmacularoedemaexploratoryanalysesoftheboltstudyreport4
AT michaelidesmichel correctionstructuralandfunctionalmeasuresofefficacyinresponsetobevacizumabmonotherapyindiabeticmacularoedemaexploratoryanalysesoftheboltstudyreport4
AT hykinphilip correctionstructuralandfunctionalmeasuresofefficacyinresponsetobevacizumabmonotherapyindiabeticmacularoedemaexploratoryanalysesoftheboltstudyreport4